Efficacy of QAX576 in Asthma

Summary

The purpose of this study is to investigate the efficacy of 24 weeks intravenous treatment with QAX576 in patients with persistent asthma not adequately controlled with inhaled corticosteroids and long acting beta2-agonists.

Timeline

Start

2010-05

Primary completion

2012-04

Completion

2012-04

Drugs

Indications